
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center.
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center (AMC). Under the agreement, the AMC will provide clinical trial advice while Novatech will assist in promoting the clinical research capabilities of the AMC internationally.
Read the full release






